Clinical Trial: A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07625280) titled 'A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH' on May 27.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of expanded Xywav dosing regimens in adult participants with narcolepsy or idiopathic hypersomnia (IH).

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Narcolepsy Idiopathic Hypersomnia

Intervention: DRUG: Xywav

0.5 g/ml calcium, magnesium, potassium, and sodium oxybates solution taken by mouth

OTHER: Placebo

Placebo solution taken by mouth

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jazz Pharmaceu...